Bribery increases drug prices by 20%: expert
Updated: 2013-07-30 10:24
(Xinhua)
|
|||||||||||
BEIJING - Twenty percent of the cost of a typical Chinese medication is spent on bribery related to medicine purchases and sales, an industry expert was quoted as saying in a Monday report.
Yu Mingde, chief of the Chinese Pharmaceutical Enterprises Association, said sales expenses generally account for 30 to 40 percent of total medicine prices, including reasonable expenditures and illegal disbursements, according to a report in the Monday edition of the China Youth Daily.
Reasonable expenditures include salaries and travel expenses for salesmen, as well as incidental expenses.
Multiple cases of bribery in the medical industry have been uncovered since early July.
On July 11, the Ministry of Public Security announced that some employees at GlaxoSmithKline (GSK) China are being investigated for suspected bribery and tax-related violations.
Other individuals involved in the case, including salesmen and doctors, are also under investigation.
In order to eradicate corruption in the medical industry, Yu said that a sound market system should be set up to generate competition among hospitals.
He also called for punishing defaulters more harshly and encouraging hospitals to take advanced steps in medical reform.
Related Stories
China to conduct medical service survey 2013-07-29 17:23
China continues medical reform efforts 2013-07-25 15:37
China to punish harmful medical practices 2013-07-23 11:07
UPS eyes China's medical products 2013-06-01 09:04
Lower drug prices expected following GSK case 2013-07-26 11:09
Details of GSK China's alleged violations revealed 2013-07-26 11:05
Today's Top News
FM welcomes deal with EU on solar panel dispute
Major SOEs eye profits from abroad
Train collision kills at least 44 in Switzerland
7-year-old 'brain dead' after swimming lesson
Families of crash victims to sue Asiana in the US
Open investigations urged after killings
Families looking to adopt turn to website
Sino-Japanese summit ruled out
Hot Topics
Lunar probe , China growth forecasts, Emission rules get tougher, China seen through 'colored lens', International board,
Editor's Picks
|
|
|
|
|
|











